Thursday, October 24, 2013 | 8:30 AM - 7:00 PM
Explore emerging basic and translational research that impacts our understanding of Parkinson's Disease and its treatment.
November 6 - 7, 2013
NIA Technical Advisor: Neil Buckholtz (National Institute on Aging)
Organizers: Alan Cross (AstraZeneca), Sonya Dougal (formerly at The New York Academy of Sciences), Howard Feldman (University of British Columbia), Surya Kolluri (Bank of America), Ian Kremer (Leaders Engaged on Alzheimer's Disease), Tetsuyuki Maruyama (Takeda), Richard C. Mohs (Eli Lilly and Company), Jeffrey S. Nye (Janssen R&D), Ronald C. Petersen (Mayo Clinic), Gregory A. Petsko (Weill Cornell Medical College), Andrea Pfeifer (AC Immune), Thomas Rooney (Sanofi), Darryle D. Schoepp (Merck and Company, Inc.), Diane Stephenson (Critical Path Institute), Rudolph E. Tanzi (Harvard Medical School), John Q. Trojanowski (University of Pennsylvania), Diana L. van de Hoef (The New York Academy of Sciences), George Vradenburg (The Global CEO Initiative on Alzheimer's Disease), Michael Weiner (University of California, San Francisco)
This conference will convene leading industry, academic, and government stakeholders to discuss how to prevent and effectively treat Alzheimer's by 2025, by coordinating with governmental efforts to build research resources, reengineer our current drug development and evaluation systems, and identify innovative technologies and financing models. The outcome of this meeting will comprise a research agenda that will delineate the pathways needed to effectively treat and prevent Alzheimer's disease by 2025.
Monday, June 3, 2013 | 1:00 PM - 4:00 PM
Organizers: John Petrini (Memorial Sloan-Kettering Cancer Center), Rodney Rothstein (Columbia University Medical Center), Lorraine Symington (Columbia University Medical Center)
Keynote Speaker: Stephen West (London Research Institute, Cancer Research UK)
Speakers: Francisca Lottersberger (de Lange lab, Rockefeller University), Gerard Mazón (Symington lab, Columbia University Medical Center), Jiyong Wang (Jia lab, Columbia University), Christian Zierhut, PhD (Funabiki lab, Rockefeller University)
The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.
Thursday, May 30, 2013 | 9:00 AM - 5:00 PM
Review progress on key aspects of the Plasmodium vivax research agenda as they pertain to malaria treatment, control, and elimination through a series of free, interdisciplinary workshops.
May 28 - 29, 2013 | Spain
Explore Plasmodium vivax biology and genomics; drug resistance and discovery; and recent clinical trial and in-field efforts in P. vivax malaria prevention, treatment, control, and elimination.
Friday, May 24, 2013 | 8:30 AM - 4:30 PM
Speakers: Scott A. Armstrong (Memorial Sloan-Kettering Cancer Center), Stephen Baylin (The Johns Hopkins University School of Medicine), Robert A. Copeland (Epizyme, Inc.), Vicki L. Goodman (GlaxoSmithKline), Haitao Li (Tsinghua University, China), X. Shirley Liu (Dana-Farber Cancer Institute), Robert Sims (Constellation Pharmaceuticals, Inc.), Alexander Tarakhovsky (The Rockefeller University)
Epigenetic research has shown that heritable changes in cancer cell transformation occur beyond the primary DNA sequence. This symposium reviews epigenetic regulators in cancer development and progress in designing therapies targeting the epigenome.
Edited by George R. Uhl
(National Institutes of Health, Baltimore, Maryland)
The fifth installment of this Annals series presents scholarly reviews on clinical, molecular, pharmacologic, imaging, genetic, and therapeutic aspects of addiction.
Organizers: Deborah R. Gustafson (SUNY Downstate Medical Center; University of Gothenburg, Sweden), John G. Kral (SUNY Downstate Medical Center), and Mandana Arabi (The Sackler Institute for Nutrition Science)
Alzheimer's disease is expected to triple in the U.S. by 2050 and obesity is already epidemic. This eBriefing presents research on the link between overnutrition and cognition that suggests obesity may play a role in age-related diseases.
Organizers: Rudolph Tanzi (Massachusetts General Hospital and Harvard Medical School), George Zavoico (MLV), and Jennifer Henry (The New York Academy of Sciences)
Speakers: Robert A. Cherny (The Florey Institute of Neuroscience and Mental Health, Australia), Steven M. Hersch (Massachusetts General Hospital and Harvard Medical School), Rudolph Tanzi (Massachusetts General Hospital and Harvard Medical School), and Daniel Tardiff (Whitehead Institute for Biomedical Research)
Transition metals including Fe, Zn, and Cu affect neurotransmission and are implicated in Parkinson's, Huntington's, and Alzheimer's diseases. This eBriefing reviews mechanisms for restoring the physiological balance of these metals in the brain.
Organizers: Zdenek Berger (Pfizer), Mercedes Beyna (Pfizer), Warren Hirst (Pfizer), and Jennifer Henry (The New York Academy of Sciences)
Autophagy is a route for degradation of aggregated cellular proteins and dysfunctional organelles. This eBriefing reviews molecular mechanisms that lead to impaired autophagy and strategies for modulating autophagy for therapeutic benefit.
September 10, 2010
Can we all be wise old owls? Science journalist Stephen Hall and neuroscientist Andre Fenton dissect what we call wisdom, from the neurons in our brain, to the social constructs behind it.
Neuroscientist Richard Restak thinks with the right mental exercises, our brains can be much better. Today he teams with writer Susan Orlean to talk about our brainy potential.
Biologist Stewart Firestein and world-renowned perfumer Christophe Laudamiel team up to tackle the science of smell.
What attracts us to a mate? Is "chemistry" really to blame for love at first sight? Biological anthropologist Helen Fisher explains the science behind our mating preferences.
Translational Medicine Initiative
The Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.
Learn more at www.nyas.org/TransMed.